Transaction Details

Footnotes

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.83 to $17.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. | 25% of the total number of shares underlying this option vested on February 14, 2019 and the remaining shares vested 1/36 per month over the next 36 months thereafter. | Granted as compensation for services.